MWNA
XENE icon

Marshall Wace North America’s Xenon Pharmaceuticals XENE Stock Holding History

Marshall Wace North America’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5.17M Sell
338,301
-72,958
-18% -$1.27M 0.02% 499
2021
Q2 		$7.66M Buy
+411,259
New +$7.58M 0.03% 428
2020
Q4 		– Sell
-24,531
Closed -$272K – 1623
2020
Q3 		$272K Sell
24,531
-6,475
-21% -$76.2K ﹤0.01% 1085
2020
Q2 		$389K Buy
31,006
+6,194
+25% +$78.8K ﹤0.01% 968
2020
Q1 		$282K Buy
24,812
+9,873
+66% +$141K ﹤0.01% 858
2019
Q4 		$196K Buy
+14,939
New +$157K ﹤0.01% 970

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return